Compare
Pick any two of the stocks we cover and see them stacked line by line — the latest price, what we think it's worth, whether it looks cheap or expensive, and the 3-month odds. Tap a name for the full study.
"Cheap / expensive" compares the latest price to our own fair-value estimate. "3-mo range" is each name's bad case and good case — the worst and best 1-in-20 of 50,000 simulated 3-month outcomes; the middle of that range is anchored to the same policy-rate carry for every name, so the range is what tells them apart. "Odds up" is the share of those outcomes that finish above the latest price. None of this is advice — it's a map of estimates and probabilities. How we build these →
Where the upside is
The same coverage list, ranked two different ways — they don't always agree, and neither is a pick. How we build these →
Biggest gap to our fair value
Latest price vs. our own fair-value estimate (base case).
Biggest simulated good case
Latest price vs. the best-1-in-20 of 50,000 simulated 3-month outcomes. A wider good case means a wider range, not a better stock.
How to read it
Cheap or expensive
We line today’s price up against our own fair-value estimate for that company. “Cheap” sits below where our work lands, “expensive” above. It’s the gap between two numbers — never a signal to act.
Odds up
The share of 50,000 simulated 3-month futures that finish above today’s price. 60% doesn’t mean it will rise — it means it rose in 6 of 10 simulated futures and fell in 4.
1- and 3-month
Each name carries a likely range, not a target. A wider range means more uncertainty, not more opportunity — the spread is the point.
What this is not
The lists on this page rank estimates, not stocks — none of it is telling you what to buy. Fair value is an estimate that can be wrong; a simulated good case is model output and one of twenty, not a promise; and a name at the top of either list today can fall off it, or turn out wrong, tomorrow. It’s a map of estimates and probabilities to think with — the decision is always yours.
Go deeper
Every number on this page comes from a full study — the company valued from the ground up, the chart read, the price run 50,000 ways, every assumption open to challenge.